Related references
Note: Only part of the references are listed.Advances in dopamine receptor agonists for the treatment of Parkinson's disease
Fabrizio Stocchi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
BUDGET IMPACT ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
D. Belousov et al.
VALUE IN HEALTH (2015)
Long-Acting Versus Standard Non-Ergot Dopamine Agonists in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials
Chang-Qing Zhou et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
R. A. Hauser et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Auditory Musical Hallucinations Associated With Extended-Release Pramipexole in an Elderly Patient With Parkinson's Disease
Hiroshi Kataoka et al.
MEDICINE (2014)
New treatments for the motor symptoms of Parkinson's disease
Anne-Catherine Vijverman et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson's disease: a randomized, double-blind, double-dummy, parallel-group study
Ying Wang et al.
TRANSLATIONAL NEURODEGENERATION (2014)
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease
A. H. V. Schapira et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Success rate, efficacy, and safety/tolerability of overnight switching from immediate-to extended-release pramipexole in advanced Parkinson's disease
A. H. V. Schapira et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Efficacy and Safety of Extended-Versus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-dopa-Undertreated Parkinson Disease: A Double-Blind, Randomized Trial
Yoshikuni Mizuno et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Extended-release pramipexole in early Parkinson disease A 33-week randomized controlled trial
W. Poewe et al.
NEUROLOGY (2011)
Extended-release pramipexole in advanced Parkinson disease A randomized controlled trial
A. H. V. Schapira et al.
NEUROLOGY (2011)
Role of Pramipexole in the Management of Parkinson's Disease
Angelo Antonini et al.
CNS DRUGS (2010)
Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease
Santiago Perez-Lloret et al.
CNS DRUGS (2010)
Efficacy, Safety, and Tolerability of Overnight Switching from Immediate- to Once Daily Extended-Release Pramipexole in Early Parkinson's Disease
Olivier Rascol et al.
MOVEMENT DISORDERS (2010)
Randomized, Double-Blind, Multicenter Evaluation of Pramipexole Extended Release Once Daily in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2010)
Pharmacokinetics of a Once-Daily Extended-Release Formulation of Pramipexole in Healthy Male Volunteers: Three Studies
Peter Jenner et al.
CLINICAL THERAPEUTICS (2009)
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease
Fabrizio Stocchi
PARKINSONISM & RELATED DISORDERS (2009)
Pramipexole in routine clinical practice - A prospective observational trial in Parkinson's disease
H Reichmann et al.
CNS DRUGS (2003)
Share Paper
